Crown Laboratories Acquires Rights for GSK’s Five OTC Drugs

 Crown Laboratories Acquires Rights for GSK’s Five OTC Drugs

Crown Laboratories Acquires Rights for GSK’s Five OTC Drugs

 

  • Crown to get North American rights of GSK’s OTC drugs namely, PanOxyl, Sarna, Zeasorb, Desenex, Mineral Ice
  • The focus of the acquisition is to build Crown’s footprints in North America with expansion of its consumer portfolio to treat multiple conditions
  • Products with indication: PanOxyl is an acne wash, Sarna is an anti-itch lotion, Zeasorb is an anti-fungal and prevention product, Desenex is an anti-fungal for athlete’s foot & Mineral Iceis a pain-relieving gel

Click here to read full press release/ article | Ref: Crown Laboratories  | Image: GSK

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post